Carbon-14 Bioconjugation: Peptides and Antibody Drug Conjugates
Almac explains how the synergy between their peptide and protein technology and radiolabeling groups can enable the manufacture of carbon-14 labeled peptides and antibody-drug conjugates (ADCs) to meet customer requirements.